全文获取类型
收费全文 | 2402篇 |
免费 | 124篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 94篇 |
妇产科学 | 26篇 |
基础医学 | 414篇 |
口腔科学 | 123篇 |
临床医学 | 126篇 |
内科学 | 539篇 |
皮肤病学 | 41篇 |
神经病学 | 274篇 |
特种医学 | 57篇 |
外科学 | 260篇 |
综合类 | 13篇 |
预防医学 | 88篇 |
眼科学 | 61篇 |
药学 | 175篇 |
中国医学 | 17篇 |
肿瘤学 | 213篇 |
出版年
2023年 | 11篇 |
2022年 | 28篇 |
2021年 | 44篇 |
2020年 | 23篇 |
2019年 | 28篇 |
2018年 | 61篇 |
2017年 | 51篇 |
2016年 | 44篇 |
2015年 | 43篇 |
2014年 | 61篇 |
2013年 | 82篇 |
2012年 | 136篇 |
2011年 | 130篇 |
2010年 | 74篇 |
2009年 | 92篇 |
2008年 | 130篇 |
2007年 | 139篇 |
2006年 | 121篇 |
2005年 | 151篇 |
2004年 | 148篇 |
2003年 | 129篇 |
2002年 | 144篇 |
2001年 | 73篇 |
2000年 | 50篇 |
1999年 | 53篇 |
1998年 | 41篇 |
1997年 | 26篇 |
1996年 | 39篇 |
1995年 | 18篇 |
1994年 | 21篇 |
1993年 | 23篇 |
1992年 | 29篇 |
1991年 | 37篇 |
1990年 | 31篇 |
1989年 | 29篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 17篇 |
1985年 | 21篇 |
1984年 | 17篇 |
1983年 | 8篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 14篇 |
1978年 | 8篇 |
1974年 | 5篇 |
1969年 | 6篇 |
1968年 | 4篇 |
1965年 | 4篇 |
排序方式: 共有2529条查询结果,搜索用时 0 毫秒
91.
92.
David Chitayat Riyana Babul Meredith M. Silver Venita Jay Ikuko E. Teshima Paul Babyn Laurence E. Becker 《American journal of medical genetics. Part A》1996,61(1):45-48
We report on a terminal deletion of the long arm of chromosome 3 [46,XX,del(3)(q27→qter)] in a female newborn infant who died 45 hours after delivery and had multiple congenital abnormalities including bilateral anophthalmia, congenital heart disease, and abnormal genitalia. The findings are compared to those of four previously reported cases with terminal del (3q). © 1996 Wiley-Liss, Inc. 相似文献
93.
94.
95.
Kyoko Itoh Takashi Kasai Yukiko Tsuji Kozo Saito Ikuko Mizuta Yoshinori Harada Shinji Sudoh Toshiki Mizuno Masanori Nakagawa Shinji Fushiki 《Neuropathology》2014,34(3):309-313
Multiple system atrophy (MSA) is an oligodendrogliopathy of presumably sporadic origin, characterized by prominent α‐synuclein inclusions with neuronal multisystem degeneration, although a few Mendelian pedigrees have been reported. Here we report two familial cases of MSA of unknown genetic background. One patient was diagnosed as a possible MSA‐C (cerebellar dysfuntion) case, and the other as clinically possible MSA‐P (parkinsonism), which turned out to be definite MSA, based on a detailed autopsy. The neuropathology showed extensive deposition of α‐synuclein in the glia as well as in the neurons located in the cerebral cortices and hippocampal systems, although neither multiplication of the SNCA gene or mutations in COQ2 gene were identified in the family concerned. 相似文献
96.
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia 总被引:15,自引:4,他引:15
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Suzuki T Kiyoi H Ozeki K Tomita A Yamaji S Suzuki R Kodera Y Miyawaki S Asou N Kuriyama K Yagasaki F Shimazaki C Akiyama H Nishimura M Motoji T Shinagawa K Takeshita A Ueda R Kinoshita T Emi N Naoe T 《Blood》2005,106(8):2854-2861
Recently, somatic mutations of the nucleophosmin gene (NPM1), which alter the subcellular localization of the product, have been reported in acute myeloid leukemia (AML). We analyzed the clinical significance of NPM1 mutations in comparison with cytogenetics, FLT3, NRAS, and TP53 mutations, and a partial tandem duplication of the MLL gene (MLL-TD) in 257 patients with AML. We found NPM1 mutations, including 4 novel sequence variants, in 64 of 257 (24.9%) patients. NPM1 mutations were associated with normal karyotype and with internal tandem duplication (ITD) and D835 mutations in FLT3, but not with other mutations. In 190 patients without the M3 French-American-British (FAB) subtype who were treated with the protocol of the Japan Adult Leukemia Study Group, multivariate analyses showed that the NPM1 mutation was a favorable factor for achieving complete remission but was associated with a high relapse rate. Sequential analysis using 39 paired samples obtained at diagnosis and relapse showed that NPM1 mutations were lost at relapse in 2 of the 17 patients who had NPM1 mutations at diagnosis. These results suggest that the NPM1 mutation is not necessarily an early event during leukemogenesis or that leukemia clones with NPM1 mutations are sensitive to chemotherapy. 相似文献
97.
Kae Kawachi Takeshi Sasaki Ayumi Murakami Takashi Ishikawa Ayako Kito Ikuko Ota Daisuke Shimizu Akinori Nozawa Yoji Nagashima Rikuo Machinami Ichiro Aoki 《Pathology, research and practice》2010
This study aimed at evaluating the usefulness of topoisomerase II alpha (TOP2A) for predicting the effect of anthracycline-based neoadjuvant chemotherapy in breast cancer. The TOP2A status was examined using fluorescent in situ hybridization (FISH) in 14 pre-chemotherapeutic breast cancer tissues, and was also assessed by immunohistochemistry (IHC) in 14 pairs of pre- and post-chemotherapeutic breast cancer specimens. TOP2A gene aberration by IHC tended to show a correlation with pathological responses but this was not statistically significant (p=0.060). On the other hand, the low TOP2A/CEP17 ratio correlated with good pathological responses (p=0.012). TOP2A overexpression was not significantly associated with response (p=0.580). Our results thus suggest that the TOP2A/CEP17 ratio may be a useful predictor of the effects of anthracycline-based neoadjuvant chemotherapy in breast cancer. 相似文献
98.
Takashi Ando Yuichi Riku Akio Akagi Hiroaki Miyahara Mitsuaki Hirano Toshimasa Ikeda Hiroyuki Yabata Ryuichi Koizumi Chisato Oba Saori Morozumi Keizo Yasui Atsuko Goto Taiji Katayama Satoko Sakakibara Ikuko Aiba Motoko Sakai Masaaki Konagaya Keiko Mori Yasuhiro Ito Hiroyuki Yuasa Masayo Nomura Kristine Joyce L. Porto Jun Mitsui Shoji Tsuji Maya Mimuro Yoshio Hashizume Masahisa Katsuno Yasushi Iwasaki Mari Yoshida 《Brain pathology (Zurich, Switzerland)》2022,32(1):e13002
The striatonigral and olivopontocerebellar systems are known to be vulnerable in multiple system atrophy (MSA), showing neuronal loss, astrogliosis, and alpha-synuclein-immunoreactive inclusions. MSA patients who displayed abundant neuronal cytoplasmic inclusions (NCIs) in the regions other than the striatonigral or olivopontocerebellar system have occasionally been diagnosed with variants of MSA. In this study, we report clinical and pathologic findings of MSA patients characterized by prominent pathologic involvement of the hippocampus. We assessed 146 consecutively autopsied MSA patients. Semi-quantitative analysis of anti-alpha-synuclein immunohistochemistry revealed that 12 of 146 patients (8.2%) had severe NCIs in two or more of the following areas: the hippocampal granule cells, cornu ammonis areas, parahippocampal gyrus, and amygdala. In contrast, the remaining 134 patients did not show severe NCIs in any of these regions. Patients with severe hippocampal involvement showed a higher representation of women (nine women/three men; Fisher's exact test, p = 0.0324), longer disease duration (13.1 ± 5.9 years; Mann–Whitney U-test, p = 0.000157), higher prevalence of cognitive impairment (four patients; Fisher's exact test, p = 0.0222), and lower brain weight (1070.3 ± 168.6 g; Mann–Whitney U-test, p = 0.00911) than other patients. The hippocampal granule cells and cornu ammonis area 1/subiculum almost always showed severe NCIs. The NCIs appeared to be ring-shaped or neurofibrillary tangle-like, fibrous configurations. Three of 12 patients also had dense, round-shaped NCIs that were morphologically similar to pick bodies. The patients with Pick body-like inclusions showed more severe atrophy of the medial temporal lobes and broader spreading of NCIs than those without. Immunohistochemistry for hyperphosphorylated tau and phosphorylated TDP-43 revealed minimal aggregations in the hippocampus of the hippocampal MSA patients. Our observations suggest a pathological variant of MSA that is characterized by severe involvement of hippocampal neurons. This phenotype may reinforce the importance of neuronal alpha-synucleinopathy in the pathogenesis of MSA. 相似文献
99.
Serum soluble interleukin‐2 receptor level is more sensitive than angiotensin‐converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement
下载免费PDF全文
![点击此处可从《The Journal of dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Chuyen Thi Hong Nguyen Naotomo Kambe Izumi Kishimoto Ikuko Ueda‐Hayakawa Hiroyuki Okamoto 《The Journal of dermatology》2017,44(7):789-797
Skin lesions in sarcoidosis are often the initial symptoms that enable the dermatologist to be the first to diagnose this granulomatosis. However, diagnosis is sometimes very problematic. In 2015, the diagnostic criteria for sarcoidosis were updated in Japan, with elevated serum soluble interleukin‐2 receptor (sIL‐2R) replacing negative tuberculin reaction. Therefore, we assessed the clinical utility of sIL‐2R compared with two other common markers, angiotensin‐converting enzyme (ACE) and lysozyme, in patients who visited the dermatology clinic. Data from 72 patients showed that sIL‐2R was more sensitive than both ACE and lysozyme in supporting a diagnosis of sarcoidosis (52.8%) compared with ACE (29%) and lysozyme (26.4%). Additionally, the sIL‐2R level was significantly higher in patients with multiple organ involvement and parenchymal infiltration. Patients with elevated sIL‐2R levels had higher serum ACE and lysozyme levels, a higher incidence of pulmonary involvement, more severe chest radiographic stage and a high incidence of expression‐specific signs by imaging analysis. Receiver–operator curve analysis showed that sIL‐2R was a better marker at the threshold cut‐off point compared with ACE and lysozyme for identifying patients with multiple organ involvement, detecting patients with pulmonary disease and parenchymal infiltration as well as predicting the presence of specific signs in the diagnosis of sarcoidosis. Moreover, the kinetics of sIL‐2R levels correlated closely with clinical manifestations, in contrast to the modest changes of ACE and lysozyme levels during the follow‐up period. In conclusion, sIL‐2R may be considered a good marker for diagnosis and a potential indicator of disease activity. 相似文献
100.
Akihiro Cho M.D. Hiroshi Yamamoto M.D. Matsuo Nagata M.D. Nobuhiro Takiguchi M.D. Hideaki Shimada M.D. Osamu Kainuma M.D. Hiroaki Souda M.D. Hisashi Gunji M.D. Akinari Miyazaki M.D. Atsushi Ikeda M.D. Tomoko Tohma M.D. Ikuko Matsumoto M.D. 《American journal of surgery》2009,198(3):445-449